Impact of the Introduction of Calcimimetics on Timing of Parathyroidectomy in Secondary and Tertiary Hyperparathyroidism

BACKGROUND: Hyperparathyroidism (HPT), both secondary and tertiary, is common in patients with end-stage renal disease, and is associated with severe bone disorders, cardiovascular complications, and increased mortality. Since the introduction of calcimimetics in 2004, treatment of HPT has shifted f...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Plas, Willemijn Y., Engelsman, Anton F., Özyilmaz, Akin, van der Horst-Schrivers, Anouk N., Meijer, Kornelis, van Dam, Gooitzen M., Pol, Robert A., de Borst, Martin H., Kruijff, Schelto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Healthcare Policy and Outcomes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179588/
https://www.ncbi.nlm.nih.gov/pubmed/27459979
http://dx.doi.org/10.1245/s10434-016-5450-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179588/
https://www.ncbi.nlm.nih.gov/pubmed/27459979
http://dx.doi.org/10.1245/s10434-016-5450-6

Ejemplares similares